NCT06880679Completed
Ultrasound Acute Chest Syndrome Sickle Cell Disease
Use of Point-of-Care Ultrasound (POCUS) for the Diagnosis of Acute Chest Syndrome in Patients With Sickle Cell Disease
Source: ClinicalTrials.gov · Last updated 2 Sept 2026
Brief summary (registry, in English)
Feasibility and reliability of ultrasound in the inpatient hematology setting.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 27 (actual)
- First submitted
- 17 Feb 2025
- Start date
- 8 Apr 2025
- Primary completion date
- 6 May 2026
- Lead sponsor
- Indiana University
- Diseases
- Sickle cell disease
- NCT number
- NCT06880679
What you commit to
- Study type: Interventional
- Participants enrolled: 27
- From 8 Apr 2025 to the primary completion date, 6 May 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Already has diagnosis of ACS prior to admission to inpatient unit
Other
- Patient is considered hemodynamically unstable to undergo consent and study procedures
- POCUS operator not available
Who the study is looking for
- Age: 0-25 years old
- Diagnosis: Patients with a documented diagnosis of sickle cell disease (any genotype)
- Disposition: Hospitalized for a SCD-related complication (e.g. VOC)
Age in the registry: - to 25 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Indiana University Coordinator of this site? Confirm its status | Indianapolis | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.